Exploring Therapeutic Potential of Emblica officinalis (Amla) Against Streptozotocin-Induced Diabetic Nephropathy in Wistar Rats.

IF 3.3 4区 医学 Q3 CHEMISTRY, MEDICINAL
Umber Younas, Muhammad Issa Khan, Imran Pasha, Beenish Israr
{"title":"Exploring Therapeutic Potential of Emblica officinalis (Amla) Against Streptozotocin-Induced Diabetic Nephropathy in Wistar Rats.","authors":"Umber Younas, Muhammad Issa Khan, Imran Pasha, Beenish Israr","doi":"10.2174/0115680266387196250714050937","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Diabetic nephropathy is a common microvascular complication that affects 20-40% of individuals with diabetes worldwide. This study aimed to evaluate the therapeutic potential of amla fruit against streptozotocin-induced diabetic nephropathy using animal models.</p><p><strong>Methods: </strong>The male Wistar rats procured for the study were divided into four groups randomly, G1 (negative control group), G2 (positive control group), G3 (rats receiving amla powder at 5% of their diet), and G4 (rats receiving amla powder at 7% of their diet). Diabetic nephropathy was induced using streptozotocin at a dose of 65 mg/kg. High-Performance Liquid Chromatography (HPLC) analysis quantified the bioactive constituents of amla. Physical, glycemic, oxidative, inflammatory, and renal biomarkers were assessed periodically.</p><p><strong>Results: </strong>HPLC analysis confirmed the presence of high levels of vitamin C, gallic acid, and quercetin in amla. Amla supplementation significantly improved body weight, controlled kidney hypertrophy, reduced blood glucose levels, enhanced antioxidant enzyme activity such as Superoxide Dismutase (SOD) and Catalase (CAT), and suppressed inflammatory cytokines. Renal function markers, including serum creatinine, blood urea nitrogen (BUN), and urine albumin, were significantly improved in the amla-treated groups. The 5% amla diet showed slightly superior effects compared to the 7% amla diet, although the differences were not statistically significant.</p><p><strong>Discussion: </strong>The findings suggested that amla mitigates DN progression by targeting key pathological pathways, particularly oxidative stress and inflammation. Its bioactive compounds appear to modulate glucose homeostasis, restore antioxidant defence, and reduce inflammatory responses. The findings also suggested a potential non-linear dose-response relationship, indicating 5% as a more effective dietary inclusion.</p><p><strong>Conclusion: </strong>Conclusively, amla fruit effectively alleviated streptozotocin-induced diabetic nephropathy in rats by controlling oxidative stress, inflammation, and hyperglycemia.</p>","PeriodicalId":11076,"journal":{"name":"Current topics in medicinal chemistry","volume":" ","pages":""},"PeriodicalIF":3.3000,"publicationDate":"2025-07-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current topics in medicinal chemistry","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2174/0115680266387196250714050937","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Diabetic nephropathy is a common microvascular complication that affects 20-40% of individuals with diabetes worldwide. This study aimed to evaluate the therapeutic potential of amla fruit against streptozotocin-induced diabetic nephropathy using animal models.

Methods: The male Wistar rats procured for the study were divided into four groups randomly, G1 (negative control group), G2 (positive control group), G3 (rats receiving amla powder at 5% of their diet), and G4 (rats receiving amla powder at 7% of their diet). Diabetic nephropathy was induced using streptozotocin at a dose of 65 mg/kg. High-Performance Liquid Chromatography (HPLC) analysis quantified the bioactive constituents of amla. Physical, glycemic, oxidative, inflammatory, and renal biomarkers were assessed periodically.

Results: HPLC analysis confirmed the presence of high levels of vitamin C, gallic acid, and quercetin in amla. Amla supplementation significantly improved body weight, controlled kidney hypertrophy, reduced blood glucose levels, enhanced antioxidant enzyme activity such as Superoxide Dismutase (SOD) and Catalase (CAT), and suppressed inflammatory cytokines. Renal function markers, including serum creatinine, blood urea nitrogen (BUN), and urine albumin, were significantly improved in the amla-treated groups. The 5% amla diet showed slightly superior effects compared to the 7% amla diet, although the differences were not statistically significant.

Discussion: The findings suggested that amla mitigates DN progression by targeting key pathological pathways, particularly oxidative stress and inflammation. Its bioactive compounds appear to modulate glucose homeostasis, restore antioxidant defence, and reduce inflammatory responses. The findings also suggested a potential non-linear dose-response relationship, indicating 5% as a more effective dietary inclusion.

Conclusion: Conclusively, amla fruit effectively alleviated streptozotocin-induced diabetic nephropathy in rats by controlling oxidative stress, inflammation, and hyperglycemia.

探索黑云母(Amla)对链脲佐菌素诱导的Wistar大鼠糖尿病肾病的治疗潜力。
导论:糖尿病肾病是一种常见的微血管并发症,影响着全世界20-40%的糖尿病患者。本研究旨在通过动物模型评价黑木果对链脲佐菌素诱导的糖尿病肾病的治疗潜力。方法:选用雄性Wistar大鼠随机分为4组,G1组(阴性对照组)、G2组(阳性对照组)、G3组(按5%的剂量给药)、G4组(按7%的剂量给药)。用链脲佐菌素(65 mg/kg)诱导糖尿病肾病。高效液相色谱法(HPLC)测定了amla的生物活性成分。定期评估生理、血糖、氧化、炎症和肾脏生物标志物。结果:高效液相色谱分析证实木参中含有高水平的维生素C、没食子酸和槲皮素。添加Amla可显著改善大鼠体重,控制肾脏肥大,降低血糖水平,提高超氧化物歧化酶(SOD)和过氧化氢酶(CAT)等抗氧化酶活性,抑制炎症细胞因子。肾功能指标,包括血清肌酐、血尿素氮(BUN)和尿白蛋白,在amla治疗组显著改善。与7%的amla饮食相比,5%的amla饮食的效果略好,尽管差异没有统计学意义。讨论:研究结果表明,amla通过靶向关键病理途径,特别是氧化应激和炎症,减轻DN的进展。其生物活性化合物似乎可以调节葡萄糖稳态,恢复抗氧化防御,减少炎症反应。研究结果还表明了潜在的非线性剂量-反应关系,表明5%的膳食添加量更有效。结论:黑木果可通过控制氧化应激、炎症和高血糖,有效减轻链脲佐菌素所致大鼠糖尿病肾病。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
6.40
自引率
2.90%
发文量
186
审稿时长
3-8 weeks
期刊介绍: Current Topics in Medicinal Chemistry is a forum for the review of areas of keen and topical interest to medicinal chemists and others in the allied disciplines. Each issue is solely devoted to a specific topic, containing six to nine reviews, which provide the reader a comprehensive survey of that area. A Guest Editor who is an expert in the topic under review, will assemble each issue. The scope of Current Topics in Medicinal Chemistry will cover all areas of medicinal chemistry, including current developments in rational drug design, synthetic chemistry, bioorganic chemistry, high-throughput screening, combinatorial chemistry, compound diversity measurements, drug absorption, drug distribution, metabolism, new and emerging drug targets, natural products, pharmacogenomics, and structure-activity relationships. Medicinal chemistry is a rapidly maturing discipline. The study of how structure and function are related is absolutely essential to understanding the molecular basis of life. Current Topics in Medicinal Chemistry aims to contribute to the growth of scientific knowledge and insight, and facilitate the discovery and development of new therapeutic agents to treat debilitating human disorders. The journal is essential for every medicinal chemist who wishes to be kept informed and up-to-date with the latest and most important advances.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信